Literature DB >> 33758570

Structure insights of SARS-CoV-2 open state envelope protein and inhibiting through active phytochemical of ayurvedic medicinal plants from Withania somnifera.

Raed Abdullah Alharbi1.   

Abstract

Coronaviruses have been causing pandemic situations across the globe for the past two decades and the focus is on identifying suitable novel targets for antivirals and vaccine development. SARS-CoV-2 encodes a small hydrophobic envelope (E) protein that mediates envelope formation, budding, replication, and release of progeny viruses from the host. Through this study, the SARS-CoV-2 E protein is studied for its open and closed state and focused in identifying antiviral herbs used in traditional medicine practices for COVID-19 infections. In this study using computational tools, we docked the shortlisted phytochemicals with the envelope protein of the SARS-CoV-2 virus and the results hint that these compounds interact with the pore-lining residues. The molecular level understanding of the open state is considered and the active inhibitors from the phytochemicals of Ayurvedic medicinal plants from Withania somnifera. We have thus identified a potential phytochemical compound that directly binds with the pore region of the E protein and thereby blocks its channel activity. Blocking the ion channel activity of E protein is directly related to the inhibition of virus replication. The study shows encouraging results on the usage of these phytochemicals in the treatment/management of SARS-CoV-2 infection.
© 2021 The Author(s).

Entities:  

Keywords:  Bioinformatics; Protein; Protein Informatics; Public Health; SARS-CoV-2; Withania somnifera

Year:  2021        PMID: 33758570      PMCID: PMC7970802          DOI: 10.1016/j.sjbs.2021.03.036

Source DB:  PubMed          Journal:  Saudi J Biol Sci        ISSN: 2213-7106            Impact factor:   4.219


  32 in total

1.  Structure-Based Virtual Screening and Biological Evaluation of a Calpain Inhibitor for Prevention of Selenite-Induced Cataractogenesis in an in Vitro System.

Authors:  Arumugam Ramachandran Muralidharan; Chandrabose Selvaraj; Sanjeev Kumar Singh; Joen-Rong Sheu; Philip A Thomas; Pitchairaj Geraldine
Journal:  J Chem Inf Model       Date:  2015-08-13       Impact factor: 4.956

2.  Exploration of protein-protein interaction effects on α-2-macroglobulin in an inhibition of serine protease through gene expression and molecular simulations studies.

Authors:  Jeyachandran Sivakamavalli; Chandrabose Selvaraj; Sanjeev Kumar Singh; Baskaralingam Vaseeharan
Journal:  J Biomol Struct Dyn       Date:  2013-10-14

3.  The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors.

Authors:  Susanne Pfefferle; Julia Schöpf; Manfred Kögl; Caroline C Friedel; Marcel A Müller; Javier Carbajo-Lozoya; Thorsten Stellberger; Ekatarina von Dall'Armi; Petra Herzog; Stefan Kallies; Daniela Niemeyer; Vanessa Ditt; Thomas Kuri; Roland Züst; Ksenia Pumpor; Rolf Hilgenfeld; Frank Schwarz; Ralf Zimmer; Imke Steffen; Friedemann Weber; Volker Thiel; Georg Herrler; Heinz-Jürgen Thiel; Christel Schwegmann-Wessels; Stefan Pöhlmann; Jürgen Haas; Christian Drosten; Albrecht von Brunn
Journal:  PLoS Pathog       Date:  2011-10-27       Impact factor: 6.823

4.  Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19.

Authors:  Chandrabose Selvaraj; Dhurvas Chandrasekaran Dinesh; Umesh Panwar; Rajaram Abhirami; Evzen Boura; Sanjeev Kumar Singh
Journal:  J Biomol Struct Dyn       Date:  2020-06-22

Review 5.  Coronavirus membrane fusion mechanism offers a potential target for antiviral development.

Authors:  Tiffany Tang; Miya Bidon; Javier A Jaimes; Gary R Whittaker; Susan Daniel
Journal:  Antiviral Res       Date:  2020-04-06       Impact factor: 5.970

6.  Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics?

Authors:  Martina Bianchi; Domenico Benvenuto; Marta Giovanetti; Silvia Angeletti; Massimo Ciccozzi; Stefano Pascarella
Journal:  Biomed Res Int       Date:  2020-05-30       Impact factor: 3.411

7.  Tailor-made multiple sequence alignments using the PRALINE 2 alignment toolkit.

Authors:  Maurits J J Dijkstra; Atze J van der Ploeg; K Anton Feenstra; Wan J Fokkink; Sanne Abeln; Jaap Heringa
Journal:  Bioinformatics       Date:  2019-12-15       Impact factor: 6.937

8.  Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease.

Authors:  Chandrabose Selvaraj; Umesh Panwar; Dhurvas Chandrasekaran Dinesh; Evzen Boura; Poonam Singh; Vikash Kumar Dubey; Sanjeev Kumar Singh
Journal:  Front Chem       Date:  2021-01-13       Impact factor: 5.221

Review 9.  Middle East Respiratory Syndrome Coronavirus (MERS-CoV): a perpetual challenge.

Authors:  Sami Al Hajjar; Ziad A Memish; Kenneth McIntosh
Journal:  Ann Saudi Med       Date:  2013 Sep-Oct       Impact factor: 1.526

Review 10.  Viroporins and inflammasomes: A key to understand virus-induced inflammation.

Authors:  N S Farag; U Breitinger; H G Breitinger; M A El Azizi
Journal:  Int J Biochem Cell Biol       Date:  2020-03-07       Impact factor: 5.085

View more
  2 in total

Review 1.  Multifaceted roles of plant derived small molecule inhibitors on replication cycle of SARS-CoV-2.

Authors:  B Uma Reddy; Nanda Kishore Routhu; Anuj Kumar
Journal:  Microb Pathog       Date:  2022-04-02       Impact factor: 3.848

2.  The Flexible, Extended Coil of the PDZ-Binding Motif of the Three Deadly Human Coronavirus E Proteins Plays a Role in Pathogenicity.

Authors:  Dewald Schoeman; Ruben Cloete; Burtram C Fielding
Journal:  Viruses       Date:  2022-08-02       Impact factor: 5.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.